4//SEC Filing
Dispersyn Gerrit 4
Accession 0001209191-18-045455
CIK 0001533040other
Filed
Aug 2, 8:00 PM ET
Accepted
Aug 3, 9:28 PM ET
Size
7.0 KB
Accession
0001209191-18-045455
Insider Transaction Report
Form 4
Dispersyn Gerrit
Chief Development Officer
Transactions
- Award
Common Stock
2018-08-01+16,000→ 16,350 total - Award
Stock option (right to buy)
2018-08-01+16,000→ 16,000 totalExercise: $1.79Exp: 2028-08-01→ Common stock (16,000 underlying)
Footnotes (2)
- [F1]Represents shares underlying a restricted stock unit, which shares will vest in four equal annual installments.
- [F2]The stock option will vest in four equal annual installments.
Documents
Issuer
RXi Pharmaceuticals Corp
CIK 0001533040
Entity typeother
Related Parties
1- filerCIK 0001704417
Filing Metadata
- Form type
- 4
- Filed
- Aug 2, 8:00 PM ET
- Accepted
- Aug 3, 9:28 PM ET
- Size
- 7.0 KB